Related Experiment Video
Updated: Jul 13, 2026
09:45
Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
When is category specific in Alzheimer's disease?
Keith R Laws1, Tim M Gale, Verity C Leeson
1Brain and Cognition Research Group, Psychology Division, Nottingham Trent University, Nottingham, UK. keith.laws@ntu.ac.uk
Summary
Category-specific disorders in Alzheimer's disease (AD) are inconsistent. Our study reveals that data artifacts, like ceiling effects, and specific statistical methods can create apparent category deficits, particularly for living items.
Area of Science:
- Neuropsychology
- Cognitive Neurology
Background:
- Category-specific disorders in Alzheimer's disease (AD) have yielded inconsistent findings.
- Potential contributing factors include control data ceiling effects, patient cognitive deficit severity, and analytical methods for single-case data.
Purpose of the Study:
- To investigate the influence of experimental design and statistical analysis on detecting category-specific naming deficits in Alzheimer's disease patients.
- To clarify whether observed category effects in AD are genuine or methodological artifacts.
Main Methods:
- Examined picture naming in Alzheimer's disease patients and matched healthy elderly controls across three experiments.
- Utilized stimuli with and without ceiling effects in controls.
- Applied various single-case analysis techniques, including chi-squared and z-scores, and compared methods that treat control samples as populations versus those that do not.
Main Results:
- Ceiling effects in control data can inflate the apparent impairment of living items and underestimate deficits in non-living items.
- Analytical methods treating control samples as populations inflated the detection of dissociations.
- Different single-case analysis techniques yielded divergent outcomes for category effects.
Conclusions:
- Methodological factors, specifically ceiling effects and certain statistical approaches, significantly impact the reported incidence of category-specific deficits in Alzheimer's disease.
- The preponderance of living versus non-living deficits in the literature may be an artifact of these methods.
- Findings challenge the reliability of previously reported category effects in AD and other neurological conditions.
More Related Videos
06:23The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
04:22Biomarker Identification for Gender Specificity of Alzheimer's Disease Based on the Glial Transcriptome Profiles
Published on: May 20, 2024
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...